Skip to content

Assessing the Efficacy and Safety of External Tibetan Medicine in the Treatment of Motor Pain After Knee Arthroplasty

Assessing the Efficacy and Safety of External Tibetan Medicine in the Treatment of Motor Pain After Knee Arthroplasty

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113830
Enrollment
Unknown
Registered
2025-12-03
Start date
2025-12-29
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motor Pain After Knee Arthroplasty

Interventions

Xiaotong Plaster Group:On the basis of conventional postoperative analgesic therapy, the medication shall be initiated 48 hours after surgery, administered 2-3 hours prior to daily exercise. The appli
Qingpeng Ointment Group:On the basis of conventional postoperative analgesic therapy, the medication shall be initiated 48 hours after surgery and administered 2-3 hours prior to daily exercise. The a
centered on the surgical area, extend posteriorly with two palm surfaces on each side of the incision, aligned horizontally with the patella. Gently massage for 5 minutes according to individual pain
Baimai Ointment Group:On the basis of conventional postoperative analgesic therapy, the ointment shall be initiated 48 hours after surgery and administered 2-3 hours prior to daily exercise. The appli
centered on the surgical area, extend posteriorly with two palm surfaces on each sid

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Ages 18-75 years, no limitation for gender. 2.Patients undergoing primary total knee arthroplasty via a standard surgical approach, with a total surgical duration of =90 minutes (tourniquet time <90 minutes), intraoperative hemostasis achieved by tourniquet release, and without postoperative drain placement. 3.Pain equal to or greater than 3 on Visual Analog Scale (VAS) immediately after active knee flexion-extension exercises, indicating significant interference with postoperative rehabilitation. 4. Received preoperative oral analgesia (celecoxib 200mg orally twice daily) one day prior to surgery, combined with general anesthesia, femoral nerve block, and intra-articular cocktail injection intraoperatively, without the use of ultra-long-acting local anesthetics such as liposomal bupivacaine. 5. Mentally lucid with intact communication abilities. 6. Signature of informed consent and complete the trial voluntarily.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to the active ingredients of the test drug, have a history of allergic reactions to traditional Chinese medicine external use, adhesive tape or have allergic constitution. 2. Patients with contraindications to conventional analgesic NSAIDs, those allergic to sulfonamides should not use this drug, and those to celecoxib should not use it. 3. Pregnant and lactating women. 4. Patients who have participated in other drug or device clinical trials within the 3 months. 5. Patients with poor compliance, who cannot adhere to medication and attend follow-up appointments on time. 6. Other circumstances that the researcher deemed unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) score assessed immediately after completion of knee flexion-extension functional exercise;

Secondary

MeasureTime frame
Proportion of patients with improved VAS scores;HSS score;Swelling improvement;

Countries

China

Contacts

Public ContactPeilai Liu

Qilu Hospital of Shandong University

199362000205@email.sdu.edu.cn+86 185 6008 2583

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026